Oil City, PA, United States of America

Jonathan G Swoboda


 

Average Co-Inventor Count = 3.5

ph-index = 2

Forward Citations = 49(Granted Patents)


Company Filing History:


Years Active: 2013-2015

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Jonathan G. Swoboda: Pioneering Glycosylation and Antimicrobial Interventions

Introduction

Jonathan G. Swoboda, an innovative inventor based in Oil City, Pennsylvania, has made significant contributions to the fields of biotechnology and pharmaceutical sciences. With a total of three patents to his name, he is particularly recognized for his groundbreaking work in the detection and modulation of O-glycosylation, as well as antimicrobial intervention strategies.

Latest Patents

Swoboda's latest patents include "Methods and compositions for detecting and modulating O-glycosylation," which focuses on innovative techniques for modulating the glycosylation of proteins. This invention holds promise for identifying therapeutic compounds for treating glycosylation-associated disorders such as neurodegeneration and diabetes, as well as de-glycosylation-associated conditions like ischemic damage and traumatic injuries.

Another notable patent is "Methods and compounds for antimicrobial intervention," which presents Wall Teichoic Acid biosynthesis inhibitors, including compound 1835F03 (targocil). This invention is particularly beneficial in treating bacterial infections and combatting Methicillin-resistant Staphylococcus aureus (MRSA). Furthermore, Swoboda's work offers valuable procedures for synthesizing these inhibitors and methods for identifying new antibacterial therapeutic agents.

Career Highlights

Jonathan Swoboda is currently affiliated with Harvard College, where he continues to expand his research and innovative contributions in his field. His work not only advances scientific understanding but also aims to develop practical solutions for health challenges facing society today.

Collaborations

Throughout his career, Swoboda has collaborated with esteemed colleagues, including Suzanne Walker Kahne and Benjamin J. Gross. These partnerships have fostered a dynamic research environment, enhancing the scope and impact of his innovative projects.

Conclusion

Jonathan G. Swoboda represents the forefront of innovation in biotechnology and pharmaceutical development. His patents reflect a commitment to addressing significant health issues through scientific research and invention. As he continues to explore new frontiers in his work, the potential for positive impact in medicine and public health remains substantial.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…